INFLUENZA IMMUNISATION
Clinical trials for INFLUENZA IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA IMMUNISATION trials appear
Sign up with your email to follow new studies for INFLUENZA IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a booster make your flu shot work better? new study investigates
⭐️ VACCINE ⭐️ CompletedThis study looked at whether adding special ingredients called adjuvants to two standard flu vaccines (Fluzone and Flublok) could make them work better. About 240 healthy adults aged 18 to 45 received either a regular flu shot or one with an adjuvant. Researchers checked for side…
Matched conditions: INFLUENZA IMMUNISATION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:54 UTC
-
New flu vaccine candidates show promise in early trial
⭐️ VACCINE ⭐️ CompletedThis Phase 1 study tested several versions of a quadrivalent recombinant influenza vaccine, some with an adjuvant, in 210 healthy adults aged 18-30 and 50+. The main goals were to check safety and measure antibody responses against flu strains. Researchers compared different H3 a…
Matched conditions: INFLUENZA IMMUNISATION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:45 UTC